🟢 Iveda Solutions is trading 7.5% up in pre-market with no confirmed company-specific catalyst

Iveda Solutions is trading at $0.25, up 7.45%, with no confirmed company-specific catalyst for the October 19 pre-market rise.

• The company’s latest release announced an IvedaAir demonstration with GlobalMed, planned for November 10.
• October 16 coverage recirculated that announcement and previously disclosed Nasdaq compliance news, rather than identifying a new catalyst.
• Broader market context is mixed and does not clearly explain the move.